{"id":165,"date":"2011-06-22T13:10:26","date_gmt":"2011-06-22T18:10:26","guid":{"rendered":"http:\/\/www.wilsonpr.com\/?p=165"},"modified":"2011-07-19T13:11:42","modified_gmt":"2011-07-19T18:11:42","slug":"p2d-bioscience-awarded-nih-grant-to-develop-pd2007","status":"publish","type":"post","link":"https:\/\/www.wilsonpr.com\/?p=165","title":{"rendered":"P2D Bioscience Awarded NIH Grant to Develop PD2007"},"content":{"rendered":"<p><a href=\"http:\/\/ctt.marketwire.com\/?release=770747&amp;id=454045&amp;type=1&amp;url=http%3a%2f%2fwww.p2dinc.com%2f\"><a href=\"http:\/\/www.p2dinc.com\"><img decoding=\"async\" loading=\"lazy\" class=\"alignleft size-medium wp-image-155\" title=\"P2D logonoline-2\" src=\"http:\/\/www.wilsonpr.com\/wp-content\/uploads\/2011\/04\/P2D-logonoline-2-300x83.jpg\" alt=\"\" width=\"300\" height=\"83\" srcset=\"https:\/\/www.wilsonpr.com\/wp-content\/uploads\/2011\/04\/P2D-logonoline-2-300x83.jpg 300w, https:\/\/www.wilsonpr.com\/wp-content\/uploads\/2011\/04\/P2D-logonoline-2.jpg 404w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a>P2D Bioscience<\/a> has received a $1.5 million grant from the National Institutes of  Health (NIH) to develop its lead dopamine transport inhibitor, <a href=\"http:\/\/ctt.marketwire.com\/?release=770747&amp;id=454048&amp;type=1&amp;url=http%3a%2f%2fwww.p2dinc.com%2fproducts.html\">PD2007<\/a>,  through IND safety and toxicology studies for future use in humans.  More than a decade of preclinical testing and numerous scientific  publications indicate PD2007&#8217;s efficacy at inhibiting dopamine transport  in multiple brain regions.<\/p>\n<p><a href=\"http:\/\/www.marketwire.com\/press-release\/P2D-Bioscience-Awarded-NIH-Grant-to-Develop-PD2007-1530217.htm\" target=\"_blank\">Click here<\/a> to read the entire release.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>P2D Bioscience has received a $1.5 million grant from the National Institutes of Health (NIH) to develop its lead dopamine transport inhibitor, PD2007, through IND safety and toxicology studies for future use in humans. More than a decade of preclinical testing and numerous scientific publications indicate PD2007&#8217;s efficacy at inhibiting dopamine transport in multiple brain [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[56,60,59,57],"_links":{"self":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts\/165"}],"collection":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=165"}],"version-history":[{"count":1,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts\/165\/revisions"}],"predecessor-version":[{"id":166,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=\/wp\/v2\/posts\/165\/revisions\/166"}],"wp:attachment":[{"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wilsonpr.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}